| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 116, 1473-1484, Copyright © 1985 by Endocrine Society
ARTICLES |
M Perrot-Applanat, F Logeat, MT Groyer-Picard and E Milgrom
Five monoclonal antibodies were used for the immunocytochemical study of mammalian progesterone receptor (PR). Initial studies were aimed at defining the optimal experimental conditions for the detection of the receptor, with special emphasis on techniques likely to be used in clinical determinations and in immunoelectron microscopic localization. Specific immunoperoxidase staining was observed either in fixed, frozen sections or in sections of paraffin-embedded tissue. The latter method allowed a better preservation of cellular structures. Among the eight fixatives tested, glutaraldehyde, picric-acid formaldehyde, and paraformaldehyde proved satisfactory. Both indirect immunoperoxidase and the indirect antibody peroxidase-antiperoxidase methods could be used. In immature rabbits or castrated guinea pigs primed by estrogen, i.e. in conditions where its ligand was absent (or present in very low concentration), the PR was confined to the nucleus of immunoreactive cells. This was the case for all the cell types of the endometrium and the myometrium, for the immunostained cells of the oviduct, cervix, vagina, pituitary gland, and for the very weakly stained cells in the liver. No staining was observed in nontarget tissues for progesterone, such as diaphragm, spleen, and small intestine. Nuclear staining was also absent when various control antibodies replaced anti-PR antibodies. This result thus generalizes the observations made on the estrogen receptor, showing that there is no translocation of the receptor from cytoplasm to nucleus under the influence of the hormone. Moreover, a marked heterogeneity in immunostaining was observed among cells of the same type in several tissues, suggesting that there could be large differences in the hormonal sensitivity of individual cells. Cellular distribution of PR immunoreactivity was studied in the uterus, cervix, oviduct, and pituitary gland of rabbits and in the uterus and vagina of guinea pigs. A labeling was observed in all the cell types of the uterus (luminal and glandular epithelium, stroma, and muscularis). In the cervix, nuclear immunostaining was observed in the connective tissue of the lamina propria and in some epithelial and muscle cells. In the vagina, PR immunoreactivity was seen in the basal layers of the stratified squamous epithelium, in the connective tissue of the lamina propria, and in the smooth muscle. In the oviduct, the luminal epithelium, the connective tissue, and the muscularis were stained. In the pituitary gland, selective nuclear labeling was observed in a few scattered cells.
This article has been cited by other articles:
![]() |
J. Martin de las Mulas, Y. Millan, and R. Dios A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor {alpha}and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog Vet. Pathol., February 1, 2005; 42(2): 200 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Peluso, A. Pappalardo, G. Fernandez, and C. A. Wu Involvement of an Unnamed Protein, RDA288, in the Mechanism through which Progesterone Mediates Its Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells Endocrinology, June 1, 2004; 145(6): 3014 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Botos, W. Xian, D. F. Smith, and C. L. Smith Progesterone Receptor Deficient in Chromatin Binding Has an Altered Cellular State J. Biol. Chem., April 9, 2004; 279(15): 15231 - 15239. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wan, K. K. Coxe, V. G. Thackray, P. R. Housley, and S. K. Nordeen Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor Mol. Endocrinol., January 1, 2001; 15(1): 17 - 31. [Abstract] [Full Text] |
||||
![]() |
D. M. Ozanne, M. E. Brady, S. Cook, L. Gaughan, D. E. Neal, and C. N. Robson Androgen Receptor Nuclear Translocation Is Facilitated by the f-Actin Cross-Linking Protein Filamin Mol. Endocrinol., October 1, 2000; 14(10): 1618 - 1626. [Abstract] [Full Text] |
||||
![]() |
R. K. Tyagi, Y. Lavrovsky, S. C. Ahn, C. S. Song, B. Chatterjee, and A. K. Roy Dynamics of Intracellular Movement and Nucleocytoplasmic Recycling of the Ligand-Activated Androgen Receptor in Living Cells Mol. Endocrinol., August 1, 2000; 14(8): 1162 - 1174. [Abstract] [Full Text] |
||||
![]() |
S. M. Enger, R. K. Ross, A. Paganini-Hill, C. L. Carpenter, and L. Bernstein Body Size, Physical Activity, and Breast Cancer Hormone Receptor Status: Results from Two Case-Control Studies Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 681 - 687. [Abstract] [Full Text] |
||||
![]() |
I. V. Smirnova, D. C. Bittel, R. Ravindra, H. Jiang, and G. K. Andrews Zinc and Cadmium Can Promote Rapid Nuclear Translocation of Metal Response Element-binding Transcription Factor-1 J. Biol. Chem., March 24, 2000; 275(13): 9377 - 9384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Galigniana, J. L. Scruggs, J. Herrington, M. J. Welsh, C. Carter-Su, P. R. Housley, and W. B. Pratt Heat Shock Protein 90-Dependent (Geldanamycin-Inhibited) Movement of the Glucocorticoid Receptor through the Cytoplasm to the Nucleus Requires Intact Cytoskeleton Mol. Endocrinol., December 1, 1998; 12(12): 1903 - 1913. [Abstract] [Full Text] |
||||
![]() |
R. K. Tyagi, L. Amazit, P. Lescop, E. Milgrom, and A. Guiochon-Mantel Mechanisms of Progesterone Receptor Export from Nuclei: Role of Nuclear Localization Signal, Nuclear Export Signal, and Ran Guanosine Triphosphate Mol. Endocrinol., November 1, 1998; 12(11): 1684 - 1695. [Abstract] [Full Text] |
||||
![]() |
J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text] |
||||
![]() |
J. K. Owens-Grillo, M. J. Czar, K. A. Hutchison, K. Hoffmann, G. H. Perdew, and W. B. Pratt A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat Domains J. Biol. Chem., June 7, 1996; 271(23): 13468 - 13475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Perrot-Applanat, C Cibert, G Geraud, J. Renoir, and E. Baulieu The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus J. Cell Sci., January 5, 1995; 108(5): 2037 - 2051. [Abstract] [PDF] |
||||
![]() |
S Dauvois, R White, and M. Parker The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling J. Cell Sci., January 12, 1993; 106(4): 1377 - 1388. [Abstract] [PDF] |
||||
![]() |
D. Hill, C. Ragsdale, and J. Brockes Isoform-specific immunological detection of newt retinoic acid receptor delta 1 in normal and regenerating limbs Development, January 3, 1993; 117(3): 937 - 945. [Abstract] [PDF] |
||||
![]() |
B Gametchu Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis Science, April 24, 1987; 236(4800): 456 - 461. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |